P/E spoločnosti Acelrx Pharmaceuticals Inc
Aká je hodnota metriky P/E spoločnosti Acelrx Pharmaceuticals Inc?
Hodnota metriky P/E spoločnosti Acelrx Pharmaceuticals Inc je 0.00
Aká je definícia metriky P/E?
P/E ratio je koeficient daný pomerom ceny akcie a príjmu spoločnosti na akciu za posledných 12 mesiacov.
The price to earnings ratio is the most widely used method for determining whether shares are accurately valued in relation to one another. But the P/E ratio does not in itself indicate whether the share is a bargain. The P/E ratio depends on the market’s perception of the risk and future growth in earnings. A company with a low P/E ratio indicates that the market perceives it as a higher risk or a lower growth or both as compared to a company with a higher price to earnings ratio. The P/E ratio of a listed company’s stock is the result of the collective perception of the market as to how risky the company is and what its earnings growth prospects are in relation to that of other companies. Investors use the P/E ratio to compare their own perception of the risk and growth of a company against the market’s collective perception of the risk and growth as reflected in the current P/E ratio.
P/E spoločností v sektore Health Care sektor na NASDAQ v porovnaní so spoločnosťou Acelrx Pharmaceuticals Inc
Čomu sa venuje spoločnosť Acelrx Pharmaceuticals Inc?
acelrx pharmaceuticals inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of moderate-to-severe acute pain. the company’s product candidates, dsuvia™ (known as arx-04 outside of the united states) and zalviso®, are designed to deliver sufentanil, a strong opioid analgesic, via a non-invasive, sublingual formulation in medical supervised settings. dsuvia is designed to deliver sublingual tablets containing 30 mcg sufentanil via a disposable, pre-filled, single-dose applicator. the phase 3 clinical program has completed and assessed the investigational product in the treatment of moderate-to-severe acute pain in patients who had undergone surgery or who presented to an emergency room with trauma or injury. in clinical studies, dsuvia demonstrated reductions in pain intensity as early as 15-to-30 minutes after the start of dosing and the most common adverse events included nausea, headache, dizziness, and v
Firmy s metrikou p/e podobnou spoločnosti Acelrx Pharmaceuticals Inc
- Hodnota metriky P/E spoločnosti Richland Resources International je N/A
- Hodnota metriky P/E spoločnosti Safeplus International je N/A
- Hodnota metriky P/E spoločnosti China Yanyuan Yuhui Natl Ed Grp je N/A
- Hodnota metriky P/E spoločnosti Acusphere je N/A
- Hodnota metriky P/E spoločnosti American Oriental Bioengineering je N/A
- Hodnota metriky P/E spoločnosti Gourmet Provisions International je N/A
- Hodnota metriky P/E spoločnosti Acelrx Pharmaceuticals Inc je 0.00
- Hodnota metriky P/E spoločnosti SEL Manufacturing je 0.00
- Hodnota metriky P/E spoločnosti China Zhong Qi Hldgs je 0.00
- Hodnota metriky P/E spoločnosti MedSmart je 0.00
- Hodnota metriky P/E spoločnosti Panbela Therapeutics je 0.00
- Hodnota metriky P/E spoločnosti Epic je 0.00
- Hodnota metriky P/E spoločnosti 2574 je 0.00